Recorded fact · drug.label_indication
drug.label_indication for cladribine|multiple-sclerosis
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 1ff9e4b6 resolves to.
The record
| Fact id | 1ff9e4b6fa8b7921866ed40c |
|---|---|
| Entity | drug: cladribine|multiple-sclerosis |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260608 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
Cladribine tablets are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease in adults.
Shown with dashes as hyphens. SHA-256 of the exact stored quote: c22101610586480ac84bf79659cc93204f5fe9e8053419cb0c6bfa86e2b62e46.
The value
{
"ingredient": "Cladribine",
"conditionId": "multiple-sclerosis",
"conditionName": "Multiple Sclerosis",
"matchedAlias": "multiple sclerosis",
"context": "indication",
"brand": "Cladribine",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "407c52d5-6498-7da5-da35-acc9ca73ced3",
"labelEffectiveTime": "20260608",
"labelsRead": 7,
"labelsNaming": 4,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 21a6566357825d3fa9cb7dff8dc026a5ac3a97b02ee739daf8d1ded2e08fcd24.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.